Does milk of magnesia impact length of hospital stay after major colorectal resection.
colorectal surgery
magnesium hydroxide
milk of magnesia
Journal
ANZ journal of surgery
ISSN: 1445-2197
Titre abrégé: ANZ J Surg
Pays: Australia
ID NLM: 101086634
Informations de publication
Date de publication:
05 2023
05 2023
Historique:
revised:
01
11
2022
received:
15
05
2022
accepted:
27
11
2022
medline:
26
5
2023
pubmed:
11
12
2022
entrez:
10
12
2022
Statut:
ppublish
Résumé
Milk of magnesia (MoM) has been reported to accelerate return of bowel function following surgery. However, there is insufficient evidence regarding the impact of MoM on postoperative recovery after colorectal surgery. We aimed to determine the impact of MoM on postoperative length of stay in patients undergoing colorectal surgery. All patients who underwent colorectal resection without an ileostomy between 2015 and 2018 were included. Patients were divided into two groups based on whether postoperative MoM (MoM) was administered or not, according to surgeons' prescribing preferences. Consecutive patients of surgeons who prescribe MoM were included in the MoM group, while consecutive patients of surgeons who prefer not to prescribe MoM served as the control group. Age, gender, preoperative comorbidities, surgical approach, length of stay, readmission, postoperative complications and mortality were evaluated and compared between the groups. A total of 3292 patients were included; 523 (15.9%) patients were prescribed MoM. Patients in the MoM group were found to be significantly older, with higher BMI and ASA class, and more often undergoing operations for cancer resection or colostomy creations, than the control group. Postoperative complications were comparable between the groups. On multivariable linear regression, MoM use was associated with a 14.1% reduction in length of stay (MoM group 4 (2; 8), control group 5 (3; 8 P = 0.006)). MoM as adjunct medication in the postoperative period following colorectal surgery is associated with reduced length of stay, without an increase in postoperative complications.
Sections du résumé
BACKGROUNDS
Milk of magnesia (MoM) has been reported to accelerate return of bowel function following surgery. However, there is insufficient evidence regarding the impact of MoM on postoperative recovery after colorectal surgery. We aimed to determine the impact of MoM on postoperative length of stay in patients undergoing colorectal surgery.
METHODS
All patients who underwent colorectal resection without an ileostomy between 2015 and 2018 were included. Patients were divided into two groups based on whether postoperative MoM (MoM) was administered or not, according to surgeons' prescribing preferences. Consecutive patients of surgeons who prescribe MoM were included in the MoM group, while consecutive patients of surgeons who prefer not to prescribe MoM served as the control group. Age, gender, preoperative comorbidities, surgical approach, length of stay, readmission, postoperative complications and mortality were evaluated and compared between the groups.
RESULTS
A total of 3292 patients were included; 523 (15.9%) patients were prescribed MoM. Patients in the MoM group were found to be significantly older, with higher BMI and ASA class, and more often undergoing operations for cancer resection or colostomy creations, than the control group. Postoperative complications were comparable between the groups. On multivariable linear regression, MoM use was associated with a 14.1% reduction in length of stay (MoM group 4 (2; 8), control group 5 (3; 8 P = 0.006)).
CONCLUSION
MoM as adjunct medication in the postoperative period following colorectal surgery is associated with reduced length of stay, without an increase in postoperative complications.
Substances chimiques
Magnesium Oxide
3A3U0GI71G
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1248-1252Informations de copyright
© 2022 The Authors. ANZ Journal of Surgery published by John Wiley & Sons Australia, Ltd on behalf of Royal Australasian College of Surgeons.
Références
Harnsberger CR, Maykel JA, Alavi K. Postoperative Ileus. Clin. Colon Rectal Surg. 2019; 32: 166-70.
Brown TA, McDonald J, Williard W. A prospective, randomized, double-blinded, placebo-controlled trial of cisapride after colorectal surgery. Am. J. Surg. 1999; 177: 399-401.
Fanning J, Yu-Brekke S. Prospective trial of aggressive postoperative bowel stimulation following radical hysterectomy. Gynecol. Oncol. 1999; 73: 412-4.
Dolberg MK, Nielsen LP, Dahl R. Pharmacokinetic profile of oral magnesium hydroxide. Basic Clin. Pharmacol. Toxicol. 2017; 120: 264-9.
Basse L, Madsen JL, Kehlet H. Normal gastrointestinal transit after colonic resection using epidural analgesia, enforced oral nutrition and laxative. Br. J. Surg. 2001; 88: 1498-500.
Hedrick TL, McEvoy MD, Mythen MMG et al. American Society for Enhanced Recovery and Perioperative Quality Initiative Joint Consensus Statement on postoperative gastrointestinal dysfunction within an enhanced recovery pathway for elective colorectal surgery. Anesth. Analg. 2018; 126: 1896-907.
Liska D, Bora Cengiz T, Novello M et al. Do patients with inflammatory bowel disease benefit from an enhanced recovery pathway? Inflamm. Bowel Dis. 2020; 26: 476-83.
Keller DS, Delaney CP, Senagore AJ, Feldman LS, SAGES SMART Task Force. Uptake of enhanced recovery practices by SAGES members: a survey. Surg. Endosc. 2017; 31: 3519-26.
Tiernan JP, Liska D. Enhanced recovery after surgery: recent developments in colorectal surgery. Surg. Clin. North Am. 2018; 98: 1241-9.
Greco M, Capretti G, Beretta L, Gemma M, Pecorelli N, Braga M. Enhanced recovery program in colorectal surgery: a meta-analysis of randomized controlled trials. World J. Surg. 2014; 38: 1531-41.
Dudi-Venkata NN, Kroon HM, Bedrikovetski S, Moore JW, Sammour T. Systematic scoping review of enhanced recovery protocol recommendations targeting return of gastrointestinal function after colorectal surgery. ANZ J. Surg. 2020; 90: 41-7.
Hendry PO, van Dam RM, Bukkems SFFW et al. Randomized clinical trial of laxatives and oral nutritional supplements within an enhanced recovery after surgery protocol following liver resection. Br. J. Surg. 2010; 97: 1198-206.
Andersen J, Christensen H, Pachler JH, Hallin M, Thaysen HV, Kehlet H. Effect of the laxative magnesium oxide on gastrointestinal functional recovery in fast-track colonic resection: a double-blind, placebo-controlled randomized study. Color. Dis. 2012; 14: 776-82.